Extrawell Pharmaceutical Holdings' (HKG:858) Earnings Might Be Weaker Than You Think
Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 13, 2025
DataAggregated Company Financials
Companies38
- 7D-0.8%
- 3M49.7%
- 1Y73.3%
- YTD81.0%
Over the last 7 days, the Pharma industry has risen 1.6%, driven by gains from China Medical System Holdings of 2.9%. During this same period, the Sunshine Lake Pharma underperformed, falling 9.7%. In the last 12 months, the industry was up 72%. Earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 13 Aug 2025 | HK$770.1b | HK$474.8b | HK$29.0b | 11.7x | 26.5x | 1.6x |
| Fri, 11 Jul 2025 | HK$666.7b | HK$475.6b | HK$28.8b | 11.2x | 23.2x | 1.4x |
| Sun, 08 Jun 2025 | HK$617.9b | HK$476.0b | HK$28.7b | 11.4x | 21.5x | 1.3x |
| Tue, 06 May 2025 | HK$513.1b | HK$467.5b | HK$28.6b | 10.4x | 17.9x | 1.1x |
| Thu, 03 Apr 2025 | HK$507.9b | HK$469.4b | HK$28.7b | 10.3x | 17.7x | 1.1x |
| Sat, 01 Mar 2025 | HK$436.2b | HK$462.0b | HK$31.9b | 8.4x | 13.7x | 0.9x |
| Mon, 27 Jan 2025 | HK$407.5b | HK$464.5b | HK$32.0b | 8.5x | 12.7x | 0.9x |
| Wed, 25 Dec 2024 | HK$432.0b | HK$460.2b | HK$31.8b | 8.5x | 13.6x | 0.9x |
| Fri, 22 Nov 2024 | HK$440.4b | HK$463.0b | HK$31.4b | 8.3x | 14x | 1x |
| Sun, 20 Oct 2024 | HK$504.7b | HK$472.2b | HK$32.8b | 7.8x | 15.4x | 1.1x |
| Tue, 17 Sep 2024 | HK$431.9b | HK$473.8b | HK$32.9b | 7.3x | 13.1x | 0.9x |
| Thu, 15 Aug 2024 | HK$435.7b | HK$466.5b | HK$33.3b | 7.5x | 13.1x | 0.9x |
| Sat, 13 Jul 2024 | HK$432.6b | HK$458.7b | HK$32.6b | 7.4x | 13.3x | 0.9x |
| Mon, 10 Jun 2024 | HK$474.5b | HK$463.7b | HK$33.9b | 8.4x | 14x | 1x |
| Wed, 08 May 2024 | HK$478.1b | HK$465.0b | HK$33.9b | 8.2x | 14.1x | 1x |
| Fri, 05 Apr 2024 | HK$447.1b | HK$465.1b | HK$36.5b | 7.6x | 12.3x | 1x |
| Sun, 03 Mar 2024 | HK$446.1b | HK$470.8b | HK$33.5b | 7.9x | 13.3x | 0.9x |
| Tue, 30 Jan 2024 | HK$419.8b | HK$471.5b | HK$33.6b | 7.2x | 12.5x | 0.9x |
| Thu, 28 Dec 2023 | HK$469.7b | HK$472.3b | HK$33.8b | 7.5x | 13.9x | 1x |
| Sat, 25 Nov 2023 | HK$513.1b | HK$472.3b | HK$32.3b | 7.3x | 15.9x | 1.1x |
| Mon, 23 Oct 2023 | HK$422.4b | HK$469.0b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Wed, 20 Sep 2023 | HK$429.3b | HK$469.5b | HK$31.6b | 6.9x | 13.6x | 0.9x |
| Fri, 18 Aug 2023 | HK$436.6b | HK$445.8b | HK$28.1b | 8.9x | 15.5x | 1x |
| Sun, 16 Jul 2023 | HK$481.2b | HK$447.5b | HK$28.0b | 9.4x | 17.2x | 1.1x |
| Tue, 13 Jun 2023 | HK$506.9b | HK$447.8b | HK$27.8b | 9.2x | 18.2x | 1.1x |
| Thu, 11 May 2023 | HK$553.5b | HK$452.8b | HK$28.4b | 9x | 19.5x | 1.2x |
| Sat, 08 Apr 2023 | HK$544.6b | HK$454.0b | HK$28.9b | 9.4x | 18.9x | 1.2x |
| Mon, 06 Mar 2023 | HK$606.4b | HK$443.5b | HK$34.0b | 12x | 17.8x | 1.4x |
| Wed, 01 Feb 2023 | HK$616.6b | HK$448.2b | HK$35.7b | 10.6x | 17.3x | 1.4x |
| Fri, 30 Dec 2022 | HK$602.4b | HK$442.1b | HK$34.8b | 11x | 17.3x | 1.4x |
| Sun, 27 Nov 2022 | HK$576.4b | HK$437.6b | HK$34.1b | 9.5x | 16.9x | 1.3x |
| Tue, 25 Oct 2022 | HK$570.5b | HK$511.8b | HK$38.7b | 8.9x | 14.7x | 1.1x |
| Thu, 22 Sep 2022 | HK$502.7b | HK$517.6b | HK$40.5b | 9.2x | 12.4x | 1x |
| Sat, 20 Aug 2022 | HK$567.4b | HK$512.0b | HK$51.1b | 7.7x | 11.1x | 1.1x |
Price to Earnings Ratio
11.1x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 26.5x which is higher than its 3-year average PE of 15.6x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.00% | |
| Healthcare | -2.60% | |
| Pharma | -0.79% | |
| Pharma | -0.79% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$38.06 | 4.6% +HK$9.9b | 115.3% | PE47.3x | |
| 1093 CSPC Pharmaceutical Group | HK$10.72 | 6.6% +HK$7.5b | 82.6% | PE26.7x | |
| 1177 Sino Biopharmaceutical | HK$7.71 | 2.8% +HK$3.8b | 155.3% | PE65.7x | |
| 867 China Medical System Holdings | HK$13.76 | 4.3% +HK$1.4b | 107.9% | PE18.8x | |
| 3933 United Laboratories International Holdings | HK$15.22 | 3.5% +HK$1.0b | 77.0% | PE10.3x |
